For the Inventor, By the Inventor

Enter assignee name

Chicago, IL, United States of America

Biovec, LLC

USPTO Granted Patents = 14

% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 46

Loading Chart...

Loading Chart...

2 inventors (with patents filed for the assignee):

Lakshman R Sehgal (14 out of 27 patents)

Jonathan Wong (14 out of 14 patents)

14 patents: Sort by Forward Citations

1. 9388427 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2016-07-12),

2. 9353383 - Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2016-05-31),

3. 8420075 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2013-04-16),

4. 8367056 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2013-02-05),

5. 8242095 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2012-08-14),

6. 8236300 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2012-08-07),

7. 8048410 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2011-11-01),

8. 7803365 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2010-09-28),

9. 7713522 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2010-05-11),

10. 7687058 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2010-03-30),

11. 7670597 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2010-03-02),

12. 7501114 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2009-03-10),

13. 7481998 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2009-01-27),

14. 7179459 - [object Object] (2007-02-20),

Company Overview

Biovec, LLC is a Chicago-based company specializing in the development and manufacturing of innovative biopharmaceutical products. The organization focuses on harnessing advanced biotechnology to create solutions that address unmet medical needs. With a commitment to research and development, Biovec engages in various domains, including drug formulation and delivery systems, aiming to enhance therapeutic efficacy and patient outcomes. The company's strategic initiatives are designed to foster collaboration and drive advancements in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#274 in Chicago, IL

#1,123 in Illinois

#22,319 in US

#42,249 in the World

Chicago, IL, United States of America

Biovec, LLC

Forward Citations = 46

2 inventors:

Lakshman R Sehgal (14 out of 27 patents)

Jonathan Wong (14 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biovec, LLC. Retrieved from https://idiyas.com/company/biovec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…